semaglutide novo nordisk patent is losing Canadian protection on a blockbuster drug after not paying a small fee Novo Nordisk scores court win

The recent SELECT trial demonstrated that semaglutide 2.4 mg (weight management dose) reduced MACE in patients with established cardiovascular disease

I never felt pushed into a quick decision

If they can start cutting meds from our plan, what is to stop them from cutting the program down the road, wrote another

10.1073/pnas.0936260100 137 TakeuchiT.KubotaT.NakanishiY.TsugawaH.SudaW.KwonA

Variants in FTO , the fat-mass and obesity-associated gene, along with GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe the metabolic terrain a clinician is prescribing into

Aim for slow, steady injections over 2030 seconds 4